Tempus Wealth Planning’s DexCom DXCM Stock Holding History

Tempus Wealth Planning’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,216	Closed	-$280K	–	275
2025 Q4	$280K	Buy	4,216 +103	+3%	+$6.66K	0.06%	229
2025 Q3	$277K	Buy	+4,113	New	+$325K	0.06%	234

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Tempus Wealth Planning's DXCM Position: Q1 2026 in Review

Tempus Wealth Planning sold out of DexCom (DXCM) in Q1 2026, closing a stake of 4,216 shares — an estimated $280K sold.

Tempus Wealth Planning first reported a position in DXCM in Q3 2025 and held it in 2 quarters. The position peaked at $280K in Q4 2025. 960 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Tempus Wealth Planning reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
Tempus Wealth Planning sold 4,216 DexCom shares in Q1 2026, an estimated $280K.
Tempus Wealth Planning first reported a position in DexCom in Q3 2025 and held it in 2 quarters.
Tempus Wealth Planning's DexCom position peaked at $280K in Q4 2025.
960 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Tempus Wealth Planning's 13F filing for Q1 2026, filed 29 Apr 2026.